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The gene for the nonapeptide neurohormone oxytocin is highly expressed in the bovine corpus luteum. 
Measurements of oxytocin-specific mRNA through the oestrous cycle of non-pregnant cows show that tran- 
scription is maximal accompanying ovulation and decreases rapidly thereafter. In contrast, immuno- 
histochemistry shows neurophysin peptide levels to be greatest at mid-cycle. Low levels of oxytocin mRNA 
are detected in follicles and in the futeolytic half of the cycle. This mRNA is virtuaily absent in the corpus 
luteum of pregnant cattle. No cyclicity is evident in ~y~thal~ic oxytocin mRNA levels. 
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1. INTRODUCTION 
The biosynthetic pathway for the hormone ox- 
ytocin has been clarified in the mammalian 
hypothalamus. A single gene comprising 3 exons 
encodes a precursor polyprotein of approx. 
12800 Da; oxytocin immediately follows the N- 
terminal signal sequence, the remainder of the 
molecule being occupied by neurophysin I, a 
polypeptide thought to act as a carrier for oxytocin 
during its axonal transport from the hypothalamus 
to the nerve endings of the posterior pituitary [I]. 
Hypothalamic oxytocin appears to be involved in 
the milk ejection reflex and in uterine contraction 
accompanying parturition. Recently, reports have 
suggested the presence of oxytocin in other 
peripheral tissues, where it may subserve quite dif- 
ferent functions 12-41. So far confirmation by se- 
quence analysis of extra-hypothalamic oxytocin 
synthesis has only been made for the bovine corpus 
luteum [5]. cDNA and primer extension sequenc- 
ing indicate that the hypothalamic and luteal ox- 
ytocin mRNAs are identical, except for a shorter 
poly(A) tail in the latter molecule f5,6]. Here, we 
show that the expression of the oxytocin gene in 
the bovine corpus luteum occurs as a singIe large 
pulse correlating with ovulation and the initial lu- 
teinizing stimuli. In contrast, oxytocin gene expres- 
sion in the hypothalamus exhibits no variation 
with the oestrous cycle. 
2. EXPERIMENTAL 
2.1. Preparation of RNA 
Corpora lutea were dissected from the ovaries of 
slaughtered cattle within 20 min of exsanguination 
and divided into portions. One portion was im- 
mediately frozen in liquid nitrogen, to be later 
crushed and directly homogenized in 5-10 vols of 
4 M guanidinium thiocyanate/l M &mercapto- 
ethanol. Total RNA was isoIated from the homog- 
enate by centrifugation through a 5.7 M CsCl 
cushion [7], followed by 2 ethanol precipitations. 
Controls indicated >70% recovery of RNA using 
this procedure, and comparison with an alternative 
technique using phenol/chloroform extraction [5] 
showed no difference either in total RNA yield or 
in proportion of oxytocin message. The remaining 
portions of corpora lutea were processed for im- 
munohistochemical analysis as in the legend to 
fig.2. 
Follicles were punctured to remove follicular 
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fluid before weighing and freezing in liquid highest level of oxytocin mRNA is present in the 
nitrogen prior to extraction. Hypothalami were first half of the oestrous cycle ([5]; unpublished), 
dissected to include -3 g tissue containing the it was not possible to correlate precisely the onset 
paraventricular, supraoptic and suprachiasmatic of oxytocin gene expression with the stage of the 
nuclei and extending anteriorly into the preoptic oestrous cycle. This can be explained in part by the 
area and posteriorly as far as the mammillary subjective assessment of the oestrous status of 
bodies. Corpora lutea from pregnant cows were commercial abattoir animals and the irregularity 
obtained from a commercial abattoir; measure- of the cycle within individual animals, some enter- 
ments of foetal crown-rump length indicated ing the luteotrophic or luteolytic phases at marked- 
pregnancy stages from 50 to 240 days. ly different rates. 
2.2. Dot blot procedure 
10 /lg of the extracted total RNA was then spot- 
ted onto nitrocellulose filters in formaldehyde 
solution [5] and hybridized at 60°C in 0.72 M 
NaCI, 40 mM Na-phosphate, pH 7.0, 4 mM 
EDTA, 0.1% (w/v) SDS, 0.02% (w/v) Ficoll400, 
0.02% (w/v) polyvinylpyrrolidone-40, 0.02% 
bovine serum albumin, 25 gg/ml denatured her- 
ring sperm DNA, with lo6 cpm/ml (> 10’ cpm/pg) 
of a 32P nick-translated DNA fragment (WI-PstI) 
comprising -190 bp from the 3’-end of the 
hypothalamic oxytocin cDNA [8]. This probe in- 
cluded no plasmid and only 12 adenosines of the 
poly(A) tail, and was highly specific for the bovine 
oxytocin gene. Autoradiograms of dot blots were 
densitometrically quantitated and compared with a 
serial dilution of oxytocin cDNA blotted with the 
RNA as internal standard. Negative controls were 
provided by bovine muscle and cerebellum RNA 
preparations. As a further control for the non- 
selectiveness of the extraction procedure, the filters 
were rehybridized with a chick @actin probe which 
cross-reacted with the bovine gene product. The 
resulting autoradiograms howed that this struc- 
tural gene was present in an approximately con- 
stant proportion throughout the oestrous cycle 
(not shown). 
To alleviate some of these difficulties, a 
laboratory herd of Angus and Angus cross-bred 
cows were slaughtered at precise dates within their 
oestrous cycles. Oestrous (day 0) was determined 
by mounting behaviour and later confirmed by the 
state of vaginal mucus, subjective appearance of 
the ovary and plasma progesterone levels at time of 
exsanguination. Corpora lutea, corpora albicanta 
and follicles from all stages of the oestrous cycle, 
as well as hypothalami of the same animals, were 
extracted for RNA using the guanidinium thio- 
cyanate procedure (see legend to table 1). Total 
RNA from individual corpora lutea of various 
stages in the oestrous cycle, as well as from animals 
through pregnancy was then spotted onto 
nitrocellulose and hybridized with a 32P-labelled 
DNA probe derived from the 3 ‘-end of the cDNA 
and specific for the oxytocin mRNA. Den- 
sitometric analysis of these dot blots yielded the 
data in table 1 and fig. 1, presented as oxytocin 
cDNA equivalents. In a parallel set of experiments 
the tissue was immunohistochemically analyzed us- 
ing neurophysin I antibodies. 
3. RESULTS AND DISCUSSION 
Unlike the hypothalamus, the corpus luteum is 
an ephemeral, steroid-producing tissue whose hor- 
monal expression is entirely dependent on the en- 
docrine status of the animal. It therefore appeared 
likely that the corpus luteum may express the ox- 
ytocin gene in a manner also reflecting the in- 
fluence of the hormonal environment, i.e. the 
oestrous cycle. 
The results show that oxytocin mRNA is already 
detectable at a low level in the mid-cycle follicles. 
On ovulation, however, there is not only a burst of 
total RNA production concomitant with the 
growth of the luteinizing tissue, but also a 
dramatic rise in the specific proportion of oxytocin 
mRNA. Maximum proportions are reached 
around day 3 and then decline swiftly, so that from 
day 11 onwards only very low levels are detectable. 
In contrast, all hypothalamic measurements re- 
mained around a constant value of - 1 ng oxytocin 
cDNA equivalent per hypothalamus and showed 
no variation dependent on oestrous status. 
Although preliminary data indicated that the 
Fig.1 expresses the levels of oxytocin mRNA in 
relation to total RNA thereby serving as an index 
of transcription and does not take into account 
growth, proliferation and demise of the corpus 
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Table 1 
Oxytocin mRNA levels (means + SD) in follicles, corpora lutea and hypothalami of Angus and Angus cross-bred cattle 
Stage of cycle n Follicular or Total RNA Oxytocin mRNA 
luteal size (g) (/lg/g tissue) 
(pg/lOcg RNA) @g/g tissue) (ng/organ) 
Follicles 
Mid-cycle 
Day 1 
Day 0 
Corpora lutea 
Day 1 
Day 3 
Day 7 
Day 11 
Day 14 
Day 17 
Day 19 
Day 21 
Day 22 
Day 24 
Pregnancy 
Hypothalamus 
2 
5 
4 
3 
4 
4 
3 
4 
2 
4 
2 
5 
3 
9 
21 
0.62 + 0.13 104+ 9 
0.25 + 0.18 278 k 179 
0.52 + 0.46 107 f 54 
0.39 + 0.02 954 + 294 
0.68 f 0.34 2204 f 1039 
3.54 f 0.95 1397 1?I 714 
3.77 f 0.76 1989 f 411 
4.30 f 1.42 2296 f 306 
3.33 f 1.89 1118 f 627 
3.07 f 0.87 1348 f 1027 
2.05 z!z 0.01 127 f 139 
0.91 * 0.37 185 & 87 
0.83 + 0.31 955 + 628 
5.80 f 1.80 636 f 467 
280 + 60 12.4 f 2.9 
10.0 f 4.7 0.10 f 0.04 0.06 f 0.03 
9.4 + 2.3 0.26 + 0.17 0.05 z!z 0.02 
16.1 + 10.7 0.12 f 0.06 0.06 f 0.04 
131.3 f 3.5 12.58 f 4.18 4.92 f 1.42 
154.8 + 42.7 36.91 + 27.67 19.55 f 8.10 
50.0 r?~ 48.1 6.65 z!z 6.33 21.37 f 18.52 
9.6 f 8.5 1.90 f 1.82 7.83 f 7.63 
10.4 + 3.3 1.90 + 1.58 6.67 f 5.37 
10.3 * 3.3 1.27 + 1.03 4.46 f 5.38 
11.5 + 5.2 1.51 f 1.56 3.54 z!z 3.08 
20.7 + 7.6 0.24 f 0.23 0.50 f 0.48 
7.1 rf: 2.7 0.09 f 0.02 0.10 f 0.05 
< 1.0 co.05 < 0.03 
1.3 f 0.9 0.05 f 0.03 0.28 + 0.09 
0.35 * 0.13 1.10 If: 0.39 
The value for one corpus albicans (see legend to fig.1) was extraordinarily high and excluded from this analysis. No 
significant trend was evident in luteal oxytocin mRNA levels from pregnant cattle 
luteum through the cycle. The endocrinological 
state of the organ is expressed more effectively as 
total oxytocin mRNA per whole organ (table 1). 
Maxima of total oxytocin mRNA are reached be- 
tween days 3 and 7 and decline more gradually, 
such that oxytocin message is still detectable, albeit 
at a low level, also in the luteolytic half of the 
cycle. 
In general, corpora albicanta as well as corpora 
lutea from pregnant animals have very low or 
undetectable amounts of oxytocin mRNA. An ex- 
ception is suggested by one corpus albicans from 
day 24 of its cycle, i.e. day 3 of the new cycle, with 
a very high level of oxytocin message (fig.1). This 
may illustrate the ephemeral recovery of a corpus 
luteum under the influence of ovulatory stimuli. 
Significantly, levels of oxytocin peptide within 
the corpus luteum remain low, similar to those in 
follicles, until about day 3, after which there is an 
increase to a peak on days 8-13 [9], several days 
after the maximum in oxytocin mRNA level. 
Similarly, immunohistochemical analysis using 
neurophysin antibodies showed that, although 
luteal cell bodies were very weakly stained on day 
3 (not shown), optimal staining was not obtained 
until day 11 (fig.2). These findings suggest that 
translation may not correlate with the highest 
levels of oxytocin mRNA and/or that processing 
of the common precursor may be delayed. This 
would reflect the physiological requirement for the 
hormone, which appears to be released in vivo 
towards the luteolytic half of the cycle. 
Although clearly connected with ovulation the 
factor(s) triggering transcription of the oxytocin 
gene are at present unknown. The marked ox- 
ytocin mRNA production of day 1 is anticipated 
by a small but clear increase of oxytocin mRNA in 
2 out of 4 preovulatory follicles from the day of 
oestrous (day 0), suggesting that follicle rupture 
alone may not be the signal. Release of the ox- 
ytocin peptide takes place mainly from day 7 on- 
wards until oestrous, resulting in a cyclic pattern of 
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Fig. 1. Follicular/luteal (A) and hypothalamic (B) levels of oxytocin mRNA through the oestrous cycle of the non- 
pregnant cow. Data are derived from table 1. One value appeared not to fit the general trend (small arrow): a corpus 
albicans from day 24 had a very high oxytocin mRNA proportion (188 pg cDNA equiv./lO pg RNA). 
oxytocin and neurophysin in the peripheral serum 
[9]. This released oxytocin has been functionally 
linked to the luteolytic role of prostaglandin FOP. in 
determining the lifespan of the corpus luteum [lo]. 
However, since oxytocin mRNA is produced max- 
imally at ovulation, the factors influencing 
transcription must be removed from those in- 
volved in luteolysis per se. Furthermore, the low 
level of oxytocin mRNA in the luteolytic phase 
also implies that stores of the nonapeptide once 
depleted probably cannot be regenerated. 
Taken together, these results show that specific 
transcription of the oxytocin gene occurs at the 
time of ovulation and is shut off again shortly 
thereafter. The absence of oestrous variation in 
hypothalamic oxytocin gene expression emphasizes 
the independent nature of the 2 expression systems 
266 
in terms of their regulatory control. Such control 
must therefore reside within the immediate cellular 
environment, probably involving differential cell- 
specific receptor systems. 
The pattern of oxytocin gene expression in the 
bovine ovary parallels close the fate of the 
granulosa-derived large luteal cells, which appear 
to predominate in the early luteotrophic half of the 
oestrous cycle [l 11. It is primarily large luteal cells 
that contain membrane-bound secretory granules 
[12], presumably the mechanism by which en- 
docrine tissues secrete peptidyl hormones. In addi- 
tion, only the large luteal cell produced oxytocin in 
vitro [ 13,141. The immunohistochemical analysis 
also clearly shows neurophysin immunoreactivity 
only in the large luteal cells of presumed granulosa 
origin, the small cells remaining unstained (fig.2). 
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Fig.2. Neurophysin immunoreactivity in day 11 corpora 
lutea. (1) Non-pregnant cow corpora lutea (day 11) 
incubated with rabbit anti-porcine oxytocin-neurophysin 
serum (1: 5000) and stained with the Vectastain ABC 
reagents (avidin-biotin-horseradish peroxidase; Vector 
Laboratories, Burlinghame, CA). Parallel sections were 
stained with haematoxylin and eosin to determine cell 
types. The small luteal cells (s) do not stain. Blood vessel 
(v). 353 x . (2) Serial section of (1) incubated with rabbit 
anti-oxytocin-neurophysin serum that was absorbed 
with bovine oxytocin-neurophysin (50 ag/ml) prior to 
staining. Large luteal cells (arrows) do not stain. Blood 
vessel (v). 353 x . A further control using rabbit pre- 
immune serum in place of anti-neurophysin, gave similar 
results (not shown). 
Within the follicle it is the granulosa cells, rather 
than the theta, which are capable of synthesizing 
oxytocin and its mRNA ([9]; unpublished). It is 
therefore tempting to postulate a regulatory link 
between this cell type and expression of the 
nonapeptide gene. 
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